Trial Profile
A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in the Management of Eltrombopag-inefficient or Relapsed ITP
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2023
Price :
$35
*
At a glance
- Drugs Diacerein (Primary) ; Eltrombopag
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 22 Nov 2020 Status changed from not yet recruiting to completed.
- 04 Dec 2018 New trial record